Volume 18 | April 2025
Is the EPS Diagnosis Leading Us Astray?
The Importance of Differentiating Tardive Dyskinesia

This newsletter is produced by Teva Pharmaceuticals, and Dr Jonathan Meyer and Dr Daniel Kremens were compensated by Teva for their insights.
EXPERT COMMENTARY
Expert Commentary With Jonathan Meyer, MD, and Daniel Kremens, MD, JD
In this interview, Dr Meyer and Dr Kremens discuss the importance of differentiating tardive dyskinesia (TD) from other drug-induced movement disorders and their approach to screening and assessment in order to successfully make the differential diagnosis. They also provide clinical insights on the appropriate treatment of TD.
Read more
Past Volumes